Ajanta Pharma Limited is a specialty pharmaceutical company focused on developing, manufacturing, and marketing branded generics and specialty formulations across emerging and regulated markets. Founded in 1973, the company has established a strong international presence spanning more than 30 countries, particularly across Asia, Africa, and the Middle East. Ajanta specializes in ophthalmology, dermatology, cardiology, pain management, anti-malarials, and gastroenterology while steadily expanding its footprint in regulated markets through generic product launches. The company operates modern manufacturing facilities that comply with stringent international quality standards, enabling exports to the United States and other developed markets. Ajanta’s strategy emphasizes first-to-market products, differentiated formulations, and continuous research and development to address evolving patient needs. Through a combination of innovation, strong physician engagement, and operational excellence, the company has emerged as one of India’s most respected specialty pharmaceutical manufacturers with a growing global reputation.
NSE: AJANTPHARM | BSE: 532331
Mumbai, Maharashtra, India
~8,000 employees
